Sulindac
In Stock•Starting at $8 for 1 g•Purity ≥ 98%
| CAS No. | 38194-50-2 |
|---|---|
| MDL No. | N/A |
| MF | C20H17FO3S |
| MW | 356.40 |
| InChI Key | MLKXDPUZXIRXEP-MFOYZWKCSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 g | 98% | $8 | In Stock | |
| 5 g | 98% | $16 | In Stock | |
| 25 g | 98% | $47 | In Stock | |
| 4*25 g | 98% | $179 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Sulindac is a monocarboxylic acid and sulfoxide, specifically 1-benzylidene-1H-indene substituted at positions 2, 3, and 5 with methyl, carboxymethyl, and fluorine groups, respectively. The benzylidene phenyl ring has a methylsulfinyl group at the para position. It functions as a prodrug for its corresponding sulfide, a non-steroidal anti-inflammatory drug used in treating acute and chronic inflammatory conditions. It acts as an EC 1.14.99.1 inhibitor, an antineoplastic agent, a non-narcotic analgesic, an antipyretic, a tocolytic agent, and an apoptosis inducer. It is also classified as an organofluorine compound and is functionally related to acetic acid.
| CAS No. | 38194-50-2 |
|---|---|
| Product Name | Sulindac |
Biological Targets
PTGS2·PTGS1
Associated Conditions
cutaneous melanoma·precancerous condition·colorectal neoplasm·breast cancer·Familial adenomatous polyposis·
* The information provided here is compiled from public sources and is for reference only.
